Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease

被引:154
作者
Torreilles, F
Touchon, J
机构
[1] UFR Pharm, CNRS, UMR 5094, Inst Biotechnol & Pharmacol, F-34093 Montpellier 5, France
[2] CHU Montpellier, Hop Gui de Chauliac, Serv Neurol B, Unite Neurol Comportementale, F-34925 Montpellier 5, France
关键词
D O I
10.1016/S0301-0082(01)00030-2
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Alzheimer's disease (AD) is an age-dependent dementia characterized by progressive loss of cognitive functions and by characteristic pathological changes in the brain: the formation of aggregates extracellularly by P-amyloid (Abeta) peptide and intracellularly by tau protein. The disease presents several major diapostic difficulties: (1) AD develops slowly, (2) analysis of damaged brain tissues is difficult, requiring a biopsy which poses ethical problems (3) no biochemical markers are available for the diagnosis and monitoring of the disease progression. Since the cerebrospinal fluid (CSF) is in contact with the extracellular space of the brain, many studies have tried to correlate the levels of the intrathecal peptides and amino acids and the development of dementia. The present review analyzes the main results of intrathecal content analyses in light of pathogenic theories proposed to explain the damage associated with AD and observed in the brain of patients by postmortem examination. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 158 条
[1]
Amouyel P, 1998, Rev Prat, V48, P1879
[2]
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[3]
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample [J].
Andreasen, N ;
Minthon, L ;
Clarberg, A ;
Davidsson, P ;
Gottfries, J ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
NEUROLOGY, 1999, 53 (07) :1488-1494
[4]
Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].
Andreasen, N ;
Hesse, C ;
Davidsson, P ;
Minthon, L ;
Wallin, A ;
Winblad, B ;
Vanderstichele, H ;
Vanmechelen, E ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680
[5]
Localization of transglutaminase in hippocampal neurons: Implications for Alzheimer's disease [J].
Appelt, DM ;
Kopen, GC ;
Boyne, LJ ;
Balin, BJ .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (12) :1421-1427
[6]
TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[7]
Bancher C, 1998, J NEURAL TRANSM-SUPP, P185
[8]
BANCHER C, 1994, ACTA NEUROPATHOL, V88, P565
[9]
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[10]
Bassett CN, 2000, MICROSC RES TECHNIQ, V50, P282, DOI 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO